Myocardiitis is a non-negligible disease in the extended family of cardiovascular diseases, and it is like a time bomb hidden deep inside the heart that poses a silent threat to the health and safety of patients.
Myocarditis is an inflammation of myocardiology. The causes of the disease are diverse and are most common with the virus, such as the Kosage virus, the Eko virus and the influenza virus. When the virus is infected, it causes an immunopathy and causes myocarditis. In addition to viral infections, bacteria, fungi, parasitic infections, etc., can also induce heartitis, although relative viral infections are rare. In addition, autoimmune diseases, drug adverse effects and physico-chemical factors can be contributing factors to myocarditis. For example, some systematic erythalamus can be co-infective with myocardial inflammation, and some chemotherapy drugs may also be toxic to myocardial muscles in the treatment of tumours, leading to the occurrence of myocarditis.
Cardiomyitis varies considerably in clinical performance, which also poses some difficulties for diagnosis. Some patients may have mild flu-like symptoms at the onset of the disease, such as heat, inactivity, cough, aldicarb, etc., which are often easily ignored, and patients may assume that they are just common upper respiratory infections and are not concerned after taking some of their own cold medicine. As the condition develops, heart-related symptoms gradually emerge. Patients experience heart palpitation, i.e. an acceleration of their own heart rate, panic, especially when it is apparent that they are manifested after activity or when they are emotional, chest pain is also one of the most common symptoms. The nature of the pain is diverse and can be insinuated, stingy or oppressive. The pain is mostly in the back of the chest or in the front of the heart, it can be emitting to the inner side of the left shoulder or to the left arm, and there may be heart failure, such as breathing difficulties, swelling, etc., or even life-threatening heart shock. For example, soon after a cold, a young sportsman gradually felt less stamina, a little movement and panting, often accompanied by panic and discomfort in the front zone, and only after a hospital examination found that he had myocarditis. A combination of factors is needed to diagnose myocarditis. First of all, detailed medical history inquiries are essential, and doctors are asked whether patients have a recent history of infection, have taken special drugs, etc. At the time of the medical examination, the doctor focused on the heart hearing, which may reveal abnormalities such as a poor heart and a change of heart. The electrocardiogram examination is an essential means of checking, and the unusual behaviour of the T-width, T-width, cardiac disorders (e.g., early strokes, room transmission retardation, etc.) indicates that the patient may be suffering from myocarditis. At the same time, the detection of signs of myocardial lesions, such as the rise in myocalcium protein, the rise in myoacid anthocyte enzymes (CK-MB) and the indication of cardiac cell damage. It is also possible to assess the structure and function of the heart, to observe whether there are motor abnormalities in the heart muscles, or changes in the size of the heart room, etc. In some suspected cases, myocardial biopsy may also be required, but myocardial biopsy is a traumatic examination and not all patients are required to do it, and there are certain risks.
Once diagnosed with myocarditis, the treatment will need to be tailored to the severity of the condition. Patients with a milder condition are treated in a way that ensures rest while at the same time, and bed rest is a key part of myocardiitis treatment, which is very helpful in reducing the heart burden and facilitating myocardial repair. The patient is generally advised to rest for three to six months, during which he/she avoids severe physical activity, stress, emotional stress and other factors that increase the heart load. Symptoms for patients, such as fever, can be treated for deheating, and heart palpitation and heart disorder can be used for specific types of anti-heart disorders. There are currently no specific antiviral drugs for myocarditis due to viral infections, but some antiviral Chinese or Chinese pharmaceutically assisted treatments are appropriate.
The treatment of patients with more severe and more complex conditions, such as heart failure, heart-borne shock, etc., is complex and requires anti-heart failure treatment, including the use of urea to reduce heart loads, vascular amplifiers to reduce pre- and post-heart loads, positive muscles to enhance myocardial constriction. For heart-borne shock patients, blood capacity is replenished in a timely manner, blood pressure is maintained using vascularly active drugs, and assistive devices, such as acoustic cysts, may be needed to improve heart function and blood circulation. At the same time, it is possible to use immunolytic therapy such as sugar cortex hormones and C-ball proteins to curb excessive immunopathy and mitigate the damage caused by myocarditis, but the timing and dose of immunosuppressive therapy needs to be strictly managed to avoid other complications due to excessive immunosuppression.
The prognosis of cardiovascular diseases varies from person to person. After timely and effective treatment, most patients are able to gradually recede from myocarditis, and the heart function is normal and well planned. However, some patients may leave behind after-effects such as cardiac disorders, myocardiosis and extended myocardia, which seriously affect the quality of life and the functioning of the heart and may even lead to sudden death. In particular, there are cases of outbreaks of myocardiitis, with rapid progress and high mortality rates, which, even after active rescue, can result in varying levels of heart failure.
Prevention of myocarditis is key. In daily life, care must be taken to improve physical fitness, physical exercise, body immunity, prevention of viral infections, high-prevalence influenza seasons and vaccination against influenza. Care should be taken to ensure personal hygiene, to wash hands, to avoid being reached in crowded places, much less in areas where air is not available, and to reduce the risk of infection. Active treatment, periodic review and care of the heart function for patients with their own immuno-diseases, to the extent that they are able to count. In the use of drugs that may cause heart damage, medical guidance is strictly followed, and physical reactions are closely observed, and if not, timely medical attention is provided.
In short, myocardiitis, as a heart-inflammated disease with hidden symptoms and diverse symptoms, can be effective in reducing the risk to the health of the patient, protecting the heart from this “invisible killer” and safeguarding the cardiovascular health of people by raising awareness of it, enhancing early diagnosis and normative treatment, and focusing on preventive measures.
